In this manuscript, the authors mainly explore the function of "TMEM16A" in the mechanism of neuropathic pain. They carried out the study by the systematic testing such as construction of CCI model, implantation of intrathecal catheter, experimental design, evaluation of thermal hyperalgesia, immunofluorescence, intact DRG preparation and electrophysiological recording, and western blot analysis, finding that T16Ainh-A01 blockade increases in CCI-induced TMEM16A expression. The results demonstrated that intrathecal administration of selective CaCCs inhibitors caused antiallodynic and antihyperalgesic effects in spinal nerve injured rats. In the end, the study revealed that TMEM16A protein expression in DRG neurons was up-regulated after chronic constriction injury but selective TMEM16A inhibitor T16Ainh-A01 reversed this increase. In the future, TMEM16A may become a potential analgesic target for preventing chronic pain measures, and TMEM16A and neuropathic pain. This manuscript is further exploring based on the article of "The association between the expression of PAR2" published before. The experimental design and illustration were meaningful. However, there are still a few issues to be clarified prior to the publication of this manuscript.
